Persistent immune imprinting occurs after vaccination with the COVID-19 XBB.1.5 mRNA booster in humans
Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved..
Immune imprinting describes how the first exposure to a virus shapes immunological outcomes of subsequent exposures to antigenically related strains. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) Omicron breakthrough infections and bivalent COVID-19 vaccination primarily recall cross-reactive memory B cells induced by prior Wuhan-Hu-1 spike mRNA vaccination rather than priming Omicron-specific naive B cells. These findings indicate that immune imprinting occurs after repeated Wuhan-Hu-1 spike exposures, but whether it can be overcome remains unclear. To understand the persistence of immune imprinting, we investigated memory and plasma antibody responses after administration of the updated XBB.1.5 COVID-19 mRNA vaccine booster. We showed that the XBB.1.5 booster elicited neutralizing antibody responses against current variants that were dominated by recall of pre-existing memory B cells previously induced by the Wuhan-Hu-1 spike. Therefore, immune imprinting persists after multiple exposures to Omicron spikes through vaccination and infection, including post XBB.1.5 booster vaccination, which will need to be considered to guide future vaccination.
| Errataetall: | |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:57 |
|---|---|
| Enthalten in: |
Immunity - 57(2024), 4 vom: 09. Apr., Seite 904-911.e4 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Tortorici, M Alejandra [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 12.04.2024 Date Revised 12.04.2024 published: Print-Electronic UpdateOf: bioRxiv. 2023 Nov 30;:. - PMID 38076876 Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.immuni.2024.02.016 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369798759 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369798759 | ||
| 003 | DE-627 | ||
| 005 | 20240412233023.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240316s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.immuni.2024.02.016 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1373.xml |
| 035 | |a (DE-627)NLM369798759 | ||
| 035 | |a (NLM)38490197 | ||
| 035 | |a (PII)S1074-7613(24)00092-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Tortorici, M Alejandra |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Persistent immune imprinting occurs after vaccination with the COVID-19 XBB.1.5 mRNA booster in humans |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 12.04.2024 | ||
| 500 | |a Date Revised 12.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a UpdateOf: bioRxiv. 2023 Nov 30;:. - PMID 38076876 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a Immune imprinting describes how the first exposure to a virus shapes immunological outcomes of subsequent exposures to antigenically related strains. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) Omicron breakthrough infections and bivalent COVID-19 vaccination primarily recall cross-reactive memory B cells induced by prior Wuhan-Hu-1 spike mRNA vaccination rather than priming Omicron-specific naive B cells. These findings indicate that immune imprinting occurs after repeated Wuhan-Hu-1 spike exposures, but whether it can be overcome remains unclear. To understand the persistence of immune imprinting, we investigated memory and plasma antibody responses after administration of the updated XBB.1.5 COVID-19 mRNA vaccine booster. We showed that the XBB.1.5 booster elicited neutralizing antibody responses against current variants that were dominated by recall of pre-existing memory B cells previously induced by the Wuhan-Hu-1 spike. Therefore, immune imprinting persists after multiple exposures to Omicron spikes through vaccination and infection, including post XBB.1.5 booster vaccination, which will need to be considered to guide future vaccination | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 mRNA vaccines | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a SARS-CoV-2 variants | |
| 650 | 4 | |a coronaviruses | |
| 650 | 4 | |a depletion assays | |
| 650 | 4 | |a immune imprinting | |
| 650 | 4 | |a memory B cells | |
| 650 | 4 | |a neutralizing antibodies | |
| 650 | 4 | |a spike glycoprotein | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 650 | 7 | |a Antibodies, Neutralizing |2 NLM | |
| 650 | 7 | |a RNA, Messenger |2 NLM | |
| 650 | 7 | |a Antibodies, Viral |2 NLM | |
| 700 | 1 | |a Addetia, Amin |e verfasserin |4 aut | |
| 700 | 1 | |a Seo, Albert J |e verfasserin |4 aut | |
| 700 | 1 | |a Brown, Jack |e verfasserin |4 aut | |
| 700 | 1 | |a Sprouse, Kaiti |e verfasserin |4 aut | |
| 700 | 1 | |a Logue, Jenni |e verfasserin |4 aut | |
| 700 | 1 | |a Clark, Erica |e verfasserin |4 aut | |
| 700 | 1 | |a Franko, Nicholas |e verfasserin |4 aut | |
| 700 | 1 | |a Chu, Helen |e verfasserin |4 aut | |
| 700 | 1 | |a Veesler, David |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Immunity |d 1994 |g 57(2024), 4 vom: 09. Apr., Seite 904-911.e4 |w (DE-627)NLM075097818 |x 1097-4180 |7 nnns |
| 773 | 1 | 8 | |g volume:57 |g year:2024 |g number:4 |g day:09 |g month:04 |g pages:904-911.e4 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.immuni.2024.02.016 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 57 |j 2024 |e 4 |b 09 |c 04 |h 904-911.e4 | ||